|
1
|
Niswander LM and Kim SY: Stratifying
osteosarcoma: Minimizing and maximizing therapy. Curr Oncol Rep.
12:266–270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Munajat I, Zulmi W, Norazman MZ and Wan
Faisham WI: Tumour volume and lung metastasis in patients with
osteosarcoma. J Orthop Surg (Hong Kong). 16:182–185. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ewens CA, Kloppsteck P, Förster A, Zhang X
and Freemont PS: Structural and functional implications of
phosphorylation and acetylation in the regulation of the AAA+
protein p97. Biochem Cell Biol. 88:41–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang Q, Song C and Li CC: Molecular
perspectives on p97-VCP: Progress in understanding its structure
and diverse biological functions. J Struct Biol. 146:44–57. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lass A, Kujawa M, McConnell E, Paton AW,
Paton JC and Wójcik C: Decreased ER-associated degradation of
alpha-TCR induced by Grp78 depletion with the SubAB cytotoxin. Int
J Biochem Cell Biol. 40:2865–2879. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Livingstone M, Ruan H, Weiner J, Clauser
KR, Strack P, Jin S, Williams A, Greulich H, Gardner J, Venere M,
et al: Valosin-containing protein phosphorylation at Ser784 in
response to DNA damage. Cancer Res. 65:7533–7540. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Long XH, Zhang ZH, Liu ZL, Huang SH and
Luo QF: Inhibiting valosin-containing protein suppresses
osteosarcoma cell metastasis via AKT/nuclear factor of kappa B
signaling pathway in vitro. Indian J Pathol Microbiol. 56:190–195.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin L and Baehrecke EH: Autophagy, cell
death, and cancer. Mol Cell Oncol. 2:e9859132015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao Z, Zhao J, Xue J, Zhao X and Liu P:
Autophagy inhibition promotes epithelial-mesenchymal transition
through ROS/HO-1 pathway in ovarian cancer cells. Am J Cancer Res.
6:2162–2177. 2016.PubMed/NCBI
|
|
11
|
Wu HM, Shao LJ, Jiang ZF and Liu RY:
Gemcitabine-induced autophagy protects human lung cancer cells from
apoptotic death. Lung. 194:959–966. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng Y, Miao H, Wu S, Yang W, Zhang Y, Xie
G, Xie X, Li J, Shi C, Ye L, et al: ABHD5 interacts with BECN1 to
regulate autophagy and tumorigenesis of colon cancer independent of
PNPLA2. Autophagy. 12:2167–2182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yin L, Liu S, Li C, Ding S, Bi D, Niu Z,
Han L, Li W, Gao D, Liu Z and Lu J: CYLD downregulates Livin and
synergistically improves gemcitabine chemosensitivity and decreases
migratory/invasive potential in bladder cancer: The effect is
autophagy-associated. Tumour Biol. 37:12731–12742. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: From dissemination to organ-specific colonization. Nat
Rev Canc. 9:274–284. 2009. View
Article : Google Scholar
|
|
15
|
Vanharanta S and Massagué J: Origins of
metastatic traits. Cancer Cell. 24:410–421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liotta LA and Kohn EC: The
microenvironment of the tumour-host interface. Nature. 411:375–379.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gilmore AP: Anoikis. Cell Death Differ. 12
(Suppl 2):S1473–S1477. 2005. View Article : Google Scholar
|
|
18
|
Lock R and Debnath J: Extracellular matrix
regulation of autophagy. Curr Opin Cell Biol. 20:583–588. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Debnath J: Detachment-induced autophagy
during anoikis and lumen formation in epithelial acini. Autophagy.
4:351–353. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY,
Hui B, Zhou J, Qiu SJ, Dai Z and Fan J: Autophagy inhibition
suppresses pulmonary metastasis of HCC in mice via impairing
anoikis resistance and colonization of HCC cells. Autophagy.
9:2056–2068. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wiederstein JL, Nolte H, Günther S, Piller
T, Baraldo M, Kostin S, Bloch W, Schindler N, Sandri M, Blaauw B,
et al: Skeletal muscle-specific methyltransferase METTL21C
trimethylates p97 and regulates autophagy-associated protein
breakdown. Cell Rep. 23:1342–1356. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ozsoy AZ, Cayli S, Sahin C, Ocakli S,
Sanci TO and Ilhan DB: Altered expression of p97/Valosin containing
protein and impaired autophagy in preeclamptic human placenta.
Placenta. 67:45–53. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li L, Zhao GD, Shi Z, Qi LL, Zhou LY and
Fu ZX: The Ras/Raf/MEK/ERK signaling pathway and its role in the
occurrence and development of HCC. Oncol Lett. 12:3045–3050. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang S, Shi R, Chen S, Wei X, Zhou Q and
Wang Y: All-trans retinoic acid inhibits the proliferation of
SGC7901 cells by regulating caveolin-1 localization via the
ERK/MAPK signaling pathway. Oncol Lett. 15:1523–1528.
2018.PubMed/NCBI
|
|
25
|
Yan KH, Yao CJ, Hsiao CH, Lin KH, Lin YW,
Wen YC, Liu CC, Yan MD, Chuang SE, Lai GM and Lee LM: Mefloquine
exerts anticancer activity in prostate cancer cells via
ROS-mediated modulation of Akt, ERK, JNK and AMPK signaling. Oncol
Lett. 5:1541–1545. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qi M and Elion EA: MAP kinase pathways. J
Cell Sci. 118:3569–3572. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang B, Liang W, Liao Y, Li Z, Wang Y and
Yan C: PEA15 promotes liver metastasis of colorectal cancer by
upregulating the ERK/MAPK signaling pathway. Oncol Rep. 41:43–56.
2019.PubMed/NCBI
|
|
28
|
Huang Y, Zou Y, Lin L, Ma X and Zheng R:
miR-101 regulates the cell proliferation and apoptosis in diffuse
large B-cell lymphoma by targeting MEK1 via regulation of the
ERK/MAPK signaling pathway. Oncol Rep. 41:377–386. 2019.PubMed/NCBI
|
|
29
|
Wang D, Xu Y, Feng L, Yin P, Song SS, Wu
F, Yan P and Liang Z: RGS5 decreases the proliferation of human
ovarian carcinoma-derived primary endothelial cells through the
MAPK/ERK signaling pathway in hypoxia. Oncol Rep. 41:165–177.
2019.PubMed/NCBI
|
|
30
|
Chen Z, Gibson TB, Robinson F, Silvestro
L, Pearson G, Xu B, Wright A, Vanderbilt C and Cobb MH: MAP kinase.
Chem Rev. 101:2449–2476. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Copetti T, Bertoli C, Dalla E, Demarchi F
and Schneider C: p65/RelA modulates BECN1 transcription and
autophagy. Mol Cell Biol. 29:2594–2608. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Copetti T, Demarchi F and Schneider C:
p65/RelA binds and activates the beclin 1 promoter. Autophagy.
5:858–859. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schweitzer K, Pralow A and Naumann M:
p97/VCP promotes Cullin-RING-ubiquitin-ligase/proteasome-dependent
degradation of IκBα and the preceding liberation of RelA from
ubiquitinated IκBα. J Cell Mol Med. 20:58–70. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
McNeill H, Knebel A, Arthur JS, Cuenda A
and Cohen P: A novel UBA and UBX domain protein that binds
polyubiquitin and VCP and is a substrate for SAPKs. Biochem J.
384:391–400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Z, Wang Y, Li C, Shi Z, Hao Q, Wang
W, Song X, Zhao Y, Jiao S and Zhou Z: The transitional endoplasmic
reticulum ATPase p97 regulates the alternative nuclear factor NF-κB
signaling via partial degradation of the NF-κB subunit p100. J Biol
Chem. 290:19558–19568. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ando K, Heymann MF, Stresing V, Mori K,
Rédini F and Heymann D: Current therapeutic strategies and novel
approaches in osteosarcoma. Cancers (Basel). 5:591–616. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yamamoto S, Tomita Y, Hoshida Y, Takiguchi
S, Fujiwara Y, Yasuda T, Yano M, Nakamori S, Sakon M, Monden M and
Aozasa K: Expression level of valosin-containing protein is
strongly associated with progression and prognosis of gastric
carcinoma. J Clin Oncol. 21:2537–2544. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yamamoto S, Tomita Y, Hoshida Y, Sakon M,
Kameyama M, Imaoka S, Sekimoto M, Nakamori S, Monden M and Aozasa
K: Expression of valosin-containing protein in colorectal
carcinomas as a predictor for disease recurrence and prognosis.
Clin Cancer Res. 10:651–657. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yamamoto S, Tomita Y, Nakamori S, Hoshida
Y, Nagano H, Dono K, Umeshita K, Sakon M, Monden M and Aozasa K:
Elevated expression of valosin-containing protein (p97) in
hepatocellular carcinoma is correlated with increased incidence of
tumor recurrence. J Clin Oncol. 21:447–452. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yamamoto S, Tomita Y, Nakamori S, Hoshida
Y, Iizuka N, Okami J, Nagano H, Dono K, Umeshita K, Sakon M, et al:
Valosin-containing protein (p97) and Ki-67 expression is a useful
marker in detecting malignant behavior of pancreatic endocrine
neoplasms. Oncology. 66:468–475. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guadamillas MC, Cerezo A and del Pozo MA:
Overcoming anoikis-pathways to anchorage-independent growth in
cancer. J Cell Sci. 124:3189–3197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu L, Zhang Q, Dai W, Li S, Feng J, Li J,
Liu T, Xu S, Wang W, Lu X, et al: Quercetin pretreatment attenuates
hepatic ischemia reperfusion-induced apoptosis and autophagy by
inhibiting ERK/NF-κB pathway. Gastroenterol Res Pract 2017.
97242172017.
|
|
43
|
Paoli P, Giannoni E and Chiarugi P:
Anoikis molecular pathways and its role in cancer progression.
Biochim Biophys Acta 1833. 3481–3498. 2013.
|
|
44
|
Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY,
Hui B, Zhou J, Qiu SJ, Dai Z and Fan J: Autophagy inhibition
suppresses pulmonary metastasis of HCC in mice via impairing
anoikis resistance and colonization of HCC cells. Autophagy.
9:2056–2068. 2013. View Article : Google Scholar : PubMed/NCBI
|
